In Q1'26, META's total operating expenses reached $23.22B USD, with R&D expenses at $17.70B USD marking a significant increase from prior quarters, while SG&A expenses stood at $5.52B USD, reflecting a moderate decline from Q4'25 levels. From Q2'23 to Q1'26, R&D expenses exhibited strong upward momentum, rising from $9.34B USD to $17.70B USD with notable accelerations in Q3'25 and Q4'25, underscoring heavy investments in innovation; in contrast, SG&A expenses showed volatility, fluctuating between $4.00B USD and $7.31B USD before stabilizing around $5.50B USD, indicating cost optimization efforts amid overall expense growth. The stacked bar chart highlights R&D as the dominant component, comprising over 75% of total expenses in recent periods, driving a clear expanding trend in META's operational spending.